Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT) : A double-blind randomised controlled trial
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 50548115
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(16)30069-1
- Title of journal
- The Lancet
- Article number
- -
- First page
- 1817
- Volume
- 387
- Issue
- 10030
- ISSN
- 0140-6736
- Open access status
- Out of scope for open access requirements
- Month of publication
- April
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
8
- Research group(s)
-
I - Infection, Immunity and Respiratory Medicine
- Citation count
- 209
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
